Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

DR. LAL PATHLABS LTD.

NSE : LALPATHLABBSE : 539524ISIN CODE : INE600L01024Industry : Hospital & Healthcare ServicesHouse : Arvind Lal

BSE1329.309.35 (+0.71 %)

PREV CLOSE ( ) 1319.95

OPEN PRICE ( ) 1322.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 8588

TODAY'S LOW / HIGH ( )1285.00 1339.35

52 WK LOW / HIGH ( )1202.72 1771.3

NSE1328.705.1 (+0.39 %)

PREV CLOSE( ) 1323.60

OPEN PRICE ( ) 1319.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 1328.70 (74)

VOLUME 167885

TODAY'S LOW / HIGH( ) 1285.00 1358.00

52 WK LOW / HIGH ( )1175.78 1770

Quarters

Select year

( in Million)

Particulars

Dec 2025

Sep 2025

Jun 2025

Mar 2025

Audited / UnAudited

UnAudited

Net Sales

6598

7306

6698

6026

Total Expenditure

4805

5065

4775

4336

PBIDT (Excl OI)

1793

2241

1923

1690

Other Income

244

248

281

258

Operating Profit

2037

2489

2204

1948

Interest

Exceptional Items

-301

PBDT

1664

2441

2157

1898

Depreciation

421

405

346

364

Profit Before Tax

1243

2036

1811

1534

Tax

329

514

471

-21

Provisions and contingencies

Profit After Tax

914

1522

1340

1555

Extraordinary Items

Prior Period Expenses

Other Adjustments

Net Profit

914

1522

1340

1555

Minority Interest

-9

-16

-7

Shares of Associates

Other related items

Misc. Expenses Written off

Consolidated Net Profit

905

1506

1324

1548

Equity Capital

1676

838

836

Face Value (IN RS)

Reserves

Calculated EPS

5.39

17.97

15.79

18.51

Calculated EPS (Annualised)

21.59

71.88

63.19

74.06

No of Public Share Holdings

78388750

39194375

38714375

38530600

% of Public Share Holdings

46.79

46.21

46.09

PBIDTM% (Excl OI)

27.17

30.67

28.71

28.04

PBIDTM%

30.87

34.06

32.90

32.32

PBDTM%

25.21

33.41

32.20

31.49

PBTM%

18.83

27.86

27.03

25.45

PATM%

13.85

20.83

20.00

25.80

Notes

Risk Disclosures on Derivatives

Quarterly Results

DR. LAL PATHLABS LTD.